Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
The paper focuses on the importance of reversible interactions to potency and mechanisms of drug resistance. It discusses the systematic assessment of non-covalent binding and chemical reactivity components to the ultimate clinical potency of emerging covalent kinase drugs. The authors deconvolute contributions from the 'reversible' component of a covalent drug, and the assay readout is considered. The study evaluates the kinetic analysis of covalent inhibition of EGFR- L858R/T790M, a disease-relevant double mutant. The data shows the kinetic analysis of various inhibitors and their impact on EGFR mutants.